FAM162A

Across TCGA pan-cancer cohorts, FAM162A mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FAM162A data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FAM162A mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated FAM162A expression acts as an unfavorable survival marker, although some lineages such as COAD and LSCC show a favorable association.

COAD, CCRCC, and LSCC are the cancer types where FAM162A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.918	.012	36	view →
CCRCC	DFS	Median	III,IV	0.426	0.718	.014	20	view →
LSCC	DFS	Median	All	0.979	0.897	.017	7	view →
HNSC	DFS	Quartile	II,III,IV	0.956	0.713	.017	5	view →
PDAC	DFS	Quartile	All	0.351	0.588	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FAM162A–COAD (DFS)

Open the COAD breakdown →